Posted on

FDA Clears Faster Diagnostic Test for MRSA

Posted on

The US Food and Drug Administration (FDA) has approved a new, faster diagnostic test based on bacterial viability and a novel technology to detect methicillin-resistant Staphylococcus aureus (MRSA) bacterial colonization, a common cause of hospital-acquired infections. The cobas vivoDx MRSA diagnostic test, from Roche Molecular Systems, may allow healthcare providers to evaluate patients for colonization with MRSA bacteria…

Read more

Posted on

FDA Clears Next-Gen Assay to Detect HIV-1 Drug Resistance Mutations

Posted on

The US Food and Drug Administration (FDA) has approved the Sentosa SQ HIV genotyping assay (Vela Diagnostics USA Inc) that uses next generation sequencing technology to detect HIV-1 drug resistance mutations from a blood sample. Recent data suggest that the percentage of people living with HIV around the world that have resistance to some HIV drugs has…

Read more

Posted on

why must some medications be taken with food?

Posted on

Have you ever been advised to take a medicine with food? How about taking a medicine with cola or avoiding grapefruit? Hundreds of medicines have food-related dosing instructions. With four out of five Australians aged above 50 taking daily medication, most people will encounter instructions about medicines and food at some point in their lives –…

Read more

Posted on

Protecting yourself during cancer treatment

Posted on

Experts recommend that patients protect themselves from infection by taking certain precautions, many of which may make for some socially awkward moments, like declining a handshake at a business meeting. But there are ways to manage both your health and your social relationships, and it often starts with a healthy dose of information. With a…

Read more

Posted on

US, Canada, Australia Simultaneously Approve Endometrial Cancer Combo

Posted on

The US Food and Drug Administration (FDA), the Australian Therapeutic Goods Administration (TGA), and Health Canada (HC) today simultaneously approved a new two-drug combination for the treatment of advanced endometrial carcinoma. The three agencies worked together under the umbrella of Project Orbis, a new FDA initiative that allows concurrent submission and review of oncology products among…

Read more